How Can Tech Companies Go From "Valuable Technology" to "Profitable Technology"? | FreeS Fund
Why should tech talent avoid "walking around with a hammer looking for nails"?
Why should tech talent avoid "walking around with a hammer looking for nails"?
By applying microRNA to early cancer screening, we can transform cancer from a terminal illness into a chronic disease that can be intercepted at an early stage.
Advancing the Commercialization of Next-Generation Digital Therapeutics
"Full Code Ahead for You"
Empowering enterprises' digital transformation.
Addressing the enormous unmet clinical needs in nephrology and oncology.
Create Lasting, Genuine Value
Focused on gut microbiome AI-driven drug discovery, with self-developed drug candidates already in registrational clinical trials.
Launching a new AI×BT strategy.
How to Lead the Pack?